Updated testing guidelines make more women eligible for herceptin, yet benefit uncertain
Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical ...
Jul 27, 2016
0
1